MRD / Regn No. : 20260000278 Date : 24/06/2026
Patient Name : Ruma Bhattacharya Age & Gender : 49 Yrs. / Female
Contact No. : 7439892176 UHID :
Ht / Wt / BMI : 158 / 49 / 19.63 BP S / BP D : /
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DM (08/Apr/2016) | DYSLIPIDEMIA (08/Apr/2026) | HYPERTENSION (08/Apr/2026) | MASLD (08/Apr/2026) |
Subjective : DM FOR 10 YEARS,UNCONTROLLED,DYSLIPIDEMIA,HYPERTENSION
Objective : NONE
Analysis : TYPE 2 DM,S2F3 FIBROSIS,DYSLIPIDEMIA
Plan : INCREASE TZD AND SEMAGLUTIDE,SEE ME IN 2 MONTHS,HOLD SGLT2I  
Salient Investigations : FASTING PLASMA GLUCOSE (FPG): 153 mg/dL | POST PRANDIAL GLUCOSE (2HPP): 278 mg/dL
S# Generic (Trade) Name Route Dosage Usage Duration
1 TABLET IMEGLIMIN SR 1000 MG
IMEGLYN SR
Medicine For GLUCOSE CONTROL 		PO 1-0-1 BEFORE FOOD
 TILL NEXT VISIT
2 ROSUVASTATIN 10 MG
ROSEDAY 10 MG
Medicine For CHOLESTEROL 		PO 0-0-1 AT BEDTIME
 TILL NEXT VISIT
MAY CAUSE FATIGUE AND MUSCLE PAIN
3 PIOGLITAZONE 15 MG
PIOZ 15 MG 		1-0-0 BEFORE FOOD
 TILL NEXT VISIT
MAY CAUSE ANKLE EDEMA AND WORSENING OF HEART FAILURE REPORT IF THERE IS INCREASED SWELLING OR SHORTNESS OF BREATH
4 INJECTION SEMAGLUTIDE 0.5 MG
SEMALIX 0.5
Medicine For DIABETES OBESITY HEART KIDNEY PROTECTION 		SQ EVERY WEEK AS DIRECTED NO RELATION TO FOOD
MAY CAUSE NAUSEA CONSTIPATION OR VISUAL DISTURBANCE
       
Refill : 0 / Substitution:    
Education :
Next Visit : 23/Aug/2026
Tests Suggested For Next Visit : FBS 2HPP HBA1C
   
   

Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu / 48748 HPRID: 71-0638-2075-7542

Disclaimer: This is an ONLINE consultation. The patient has not been physically examined. The prescription or advice is based on the patient's description of the problem which is given above and also explained over video consultation.
This is a Computer generated Prescription

Powered By: